Another update by Incannex on the NASDAQ tonight.
Potentially a very big market disruptor arriving.
RESMED should take them out soon.
Short Summary Below.
This trial is significant as it follows a successful Phase 2A study that showed a greater than 50% reduction in the apnea hypopnea index (AHI) at low doses, with 25% of patients achieving over 80% reduction.
The trial will span 52 weeks, involving 560 patients across the US, EU, and UK, and aims to provide an alternative to CPAP machines which many patients find intolerable.
www.incannex.com
- Forums
- ASX - By Stock
- Takeover Target Potential?
Another update by Incannex on the NASDAQ tonight.Potentially a...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$33.15 |
Change
-0.340(1.02%) |
Mkt cap ! $21.30B |
Open | High | Low | Value | Volume |
$33.21 | $33.45 | $33.14 | $45.70M | 1.376M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 582 | $33.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$33.17 | 6832 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 582 | 33.140 |
1 | 4400 | 33.110 |
2 | 725 | 33.100 |
1 | 400 | 33.080 |
2 | 671 | 33.060 |
Price($) | Vol. | No. |
---|---|---|
33.170 | 6832 | 2 |
33.180 | 6635 | 1 |
33.190 | 2727 | 1 |
33.200 | 10096 | 1 |
33.210 | 4381 | 1 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |